Tenon Medical, Inc. current report, 17 May 2023

Tenon Medical, Inc. (TNON) - Form 8-K Summary

Business Context and Reporting Period

This Current Report on Form 8-K, dated July 11, 2023, covers events occurring between May 17, 2023, and July 10, 2023. Tenon Medical, Inc., a Delaware corporation listed on The Nasdaq Capital Market, reports on its compliance status regarding Nasdaq listing rules.

Key Financial Metrics and Liquidity

The filing does not provide comprehensive revenue, profit, or cash flow statements. However, it discloses specific liquidity and equity events:

  • Stockholders' Equity Requirement: The company was notified of non-compliance with the minimum stockholders' equity requirement of $2,500,000 (Nasdaq Rule 5550(b)(1)).
  • Capital Raise: On June 16, 2023, the company consummated a public offering of 10,000,000 units (one share of common stock and two warrants per unit).
  • Net Proceeds: The public offering generated net proceeds of $4,866,000.

Material Changes

The primary material change reported is the restoration of compliance with Nasdaq listing standards. Following a notice of non-compliance received on May 17, 2023, the company executed a public offering. As of July 10, 2023, management believes the company is in compliance with the Minimum Equity Requirement due to the capital raised.

Outlook, Risks, and Contingencies

Nasdaq will continue to monitor the company's ongoing compliance with the Minimum Equity Requirement. The filing notes a significant contingency: if the company fails to evidence compliance at the time of its next periodic report, it may be subject to delisting from The Nasdaq Capital Market.

Investor Verification Checklist

  • Verify the company's current stockholders' equity balance in the most recent periodic report (10-Q or 10-K) to confirm sustained compliance with the $2,500,000 threshold.
  • Review the terms of the 10,000,000 units issued in June 2023, specifically the exercise price and expiration of the warrants included in the offering.
  • Monitor upcoming periodic filings for any further notices from Nasdaq regarding continued listing standards.